Eton Price To Book Ratio from 2010 to 2024
| ETON Stock | USD 3.61 0.03 0.82% |
Price To Book Ratio | First Reported 2010-12-31 | Previous Quarter 7.25765349 | Current Value 5.78 | Quarterly Volatility 3.6885124 |
Check Eton Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eton Pharmaceuticals' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 561.6 K or Selling General Administrative of 12.9 M, as well as many indicators such as Price To Sales Ratio of 3.37, Dividend Yield of 0.0214 or PTB Ratio of 5.78. Eton financial statements analysis is a perfect complement when working with Eton Pharmaceuticals Valuation or Volatility modules.
Eton | Price To Book Ratio |
Latest Eton Pharmaceuticals' Price To Book Ratio Growth Pattern
Below is the plot of the Price To Book Ratio of Eton Pharmaceuticals over the last few years. It is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter’s book value per share. Eton Pharmaceuticals' Price To Book Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eton Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Price To Book Ratio | 10 Years Trend |
|
Price To Book Ratio |
| Timeline |
Eton Price To Book Ratio Regression Statistics
| Arithmetic Mean | 4.07 | |
| Geometric Mean | 2.85 | |
| Coefficient Of Variation | 90.61 | |
| Mean Deviation | 3.09 | |
| Median | 1.49 | |
| Standard Deviation | 3.69 | |
| Sample Variance | 13.61 | |
| Range | 10.6278 | |
| R-Value | 0.66 | |
| Mean Square Error | 8.28 | |
| R-Squared | 0.43 | |
| Significance | 0.01 | |
| Slope | 0.54 | |
| Total Sum of Squares | 190.47 |
Eton Price To Book Ratio History
About Eton Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Eton Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Eton Pharmaceuticals investors use historical funamental indicators, such as Eton Pharmaceuticals's Price To Book Ratio, to determine how well the company is positioned to perform in the future. Although Eton Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Eton Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Eton Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Eton Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Eton Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Book Ratio | 7.26 | 5.78 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Eton Stock
When determining whether Eton Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eton Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eton Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eton Pharmaceuticals Stock:Check out the analysis of Eton Pharmaceuticals Correlation against competitors. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Earnings Share 0.03 | Revenue Per Share 1.335 | Quarterly Revenue Growth 0.502 | Return On Assets 0.0124 |
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.